While certain autoimmune diseases are linked to an increased risk of digestive system cancers, people with multiple sclerosis ...

High-dose vitamin D as an add-on treatment for MS provides modest but significant benefits to patients, a meta-analysis ...

Columnist Leigh Anne Nelson once chalked up new neurological symptoms to her MS, but she now realizes that assumption could ...

Scientists discovered a genetic marker that predicts before MS therapy whether glatiramer acetate or interferon is likely to ...

People who develop MS begin using healthcare services more frequently up to 15 years before their MS symptoms first appear.

The experimental CAR T-cell therapy treatment was given as part of a clinical trial that's enrolling adults with progressive ...

Enrollment is complete for a Phase 2 trial testing Zenas Biopharma's obexelimab in relapsing MS, with results expected later ...

Columnist Desiree Lama has had to find some self-care strategies for managing her MS while also staying atop her work as a ...

Better physical performance is associated with higher cognitive function in people with MS, particularly in those with ...

Beneficiaries of plans that covered fewer than the median number of DMTs in the past year were more likely to have a relapse, ...

Quantum signed a manufacturing agreement for the production of Lucid-MS as it prepares for a Phase 2 trial of the ...

Lucid-MS, Quantum Biopharma's oral multiple sclerosis therapy candidate, was not toxic and had no side effects in healthy ...